- Home
- / Dr. Reddy's Laboratories
Dr. Reddy's Laboratories
Stock Price
₹1.3 K
2024-10-29
Market Capitalization
₹1 T
2024-10-29
Revenue
₹335.9 B
FY, 2026
Dr. Reddy's Laboratories Summary
Company Summary
- Overview
- Dr. Reddy's Laboratories is a company providing pharmaceutical solutions. It offers generics, active pharmaceutical ingredients, biologics products, etc. The company is engaged in drug research, development, manufacturing, and digitalization services.
- Type
- Public
- Status
- Active
- Founded
- 1984
- HQ
- Hyderabad, IN | view all locations
- Website
- http://www.drreddys.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Erez Israeli, Chief Executive Officer
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Chief Executive Officer, API and Services
Operating MetricsView all
Manufacturing Facilities
23
4.5%
FY, 2024
Types of Clients Served
5
16.7%
FY, 2024
Countries
76
2.7%
FY, 2024
LocationsView all
45 locations detected
Hyderabad, TG HQ
India
8-2-337, Road No. 3, Banjara Hills
Middleburgh, NY
United States
1974 Route 145
Princeton, NJ
United States
107 College Road East
Shreveport, LA
United States
8800 Line Ave
Melbourne, VIC
Australia
Suite 3.03, Level 3/390 St Kilda Road
São Paulo, SP
Brazil
Av.Guido Caloi, 1.985 - Cj.11
Dr. Reddy's Laboratories Financials
Summary Financials
- Revenue (FY, 2026)
- ₹335.9B
- Gross profit (FY, 2026)
- ₹228.2B
- Net income (FY, 2026)
- ₹41.6B
- Cash (FY, 2026)
- ₹33.5B
- EBIT (FY, 2026)
- ₹61.2B
- Enterprise value
- $1.1T